Liposomes: quo vadis?

Liposomes have matured as a delivery system for therapeutic agents. It has taken two decades to develop the liposome carrier concept to a pharmaceutical product level, but commercial preparations are now available in important disease areas. In this review, the authors provide their perspective on where the field is going and where opportunities can be found for rational improvement of drug therapy with liposomes.